US Nuclear Strategic Investment in Fusion Energy Breakthrough Targets $7.5 Billion Medical Radioisotope Market for First Use
LOS ANGELES, CA, Jan. 22, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Less than one month ago, US Nuclear Corp. (OTC-QB: UCLE) announced that MIFTI, a company that US Nuclear Corp has invested in, reported breakout fusion power test results on the 4 Mega Ampere Machine at L3 Harris Lab in San Leandro, California. At about the same time, Cleantech Group, a well-known expert in clean technologies, published a report, in which Dr. Hafiz Rahman, MIFTI President and Chief Scientist was quoted, “MIFTI’s recent experiments at L3 Harris produced a neutron yield of 10 to the 11th power; the highest level ever achieved by any private company in the world.”
Related news for (UCLE)
- US Nuclear Corp. Announces First Quarter 2024 Results
- US Nuclear’s Unparalleled PFAS Monitoring Products in Spotlight as EPA Sets First-Ever Limits on PFAS
- US Nuclear Delivers First Batch of Tritium Monitoring Systems to Nation’s Largest Public Power Company
- US Nuclear’s Overhoff Delivers the Goods to U.S. DOE
- US Nuclear’s Overhoff Branch is Fusion Energy’s Go-To Tritium Monitoring Solution